XEOS Publishes BrIMA Study in JAMA Surgery on Specimen PET-CT for Breast Cancer Surgery
XEOS announced the publication of the BrIMA study in JAMA Surgery, demonstrating that the AURA 10® PET-CT system significantly improves intraoperative margin assessment during breast-conserving surgery. The multicenter study showed that this technology provides actionable insights that help surgeons identify and manage positive margins more effectively, potentially reducing the need for reoperations.
Multicenter study demonstrates specimen PET-CT provides actionable information at the point of decision-making, improving identification and management of positive margins during breast-conserving surgery GHENT, Belgium, June 18, 2026 /PRNewswire/ — XEOS, a medical technology company…